Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.
about
SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracyNon-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future ProspectsToo much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyondRecent advances in prenatal genetic screening and testingAccuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysisSpanish- and English-Speaking Pregnant Women's Views on cfDNA and Other Prenatal Screening: Practical and Ethical Reflections.Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis.The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood.Non-invasive prenatal detection of trisomy 13 using a single nucleotide polymorphism- and informatics-based approach.Placental mosaicism for Trisomy 13: a challenge in providing the cell-free fetal DNA testingSingle-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohortNoninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics.Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidiesAnalysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral centerExome Sequencing in Fetuses with Structural MalformationsDigynic triploidy: utility and challenges of noninvasive prenatal testingThe First Case Report in Italy of Di George Syndrome Detected by Noninvasive Prenatal Testing.NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result.Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS)Cell free fetal DNA testing in maternal blood of Romanian pregnant womenIntegration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and AustriaClinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome.IONA test for first-trimester detection of trisomies 21, 18 and 13.A Case of False Negative NIPT for Down Syndrome-Lessons Learned.Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.Non-invasive prenatal testing for aneuploidy: current status and future prospects.What does next-generation sequencing mean for prenatal diagnosis?Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories.Clinical implementation of NIPT - technical and biological challenges.Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting.The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon.Benefits and limitations of prenatal screening for Prader-Willi syndrome.Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.Prenatal and pre-implantation genetic diagnosis.
P2860
Q24627800-8D4EBB1A-64FF-47E1-9A11-2D846451B1EDQ26827338-8B83BACB-D5CE-4CFC-B1A7-AD308052AF78Q26998800-A8B4E72F-F340-4102-9735-077716DC2ADBQ28071888-94CD4B66-B4B5-4DE2-A976-3977C51DF3BEQ28072788-E5FC7BFB-DE0F-49D9-BA57-A3ADFF75B0C6Q30197052-AD0111CF-8AEA-484B-922C-E738AF37676DQ30234867-AB75C4E9-6048-4AE3-8B6E-F9D2FEDA267AQ30250029-B26978E7-C4CE-4401-8AE7-3BA5C3E601EAQ33572406-F0016FD5-5F25-41AB-BB90-B26C54842A4BQ33578055-72A58B45-2036-4BA3-B57E-7BF8604BD3A9Q33591919-3AF3E8FB-C2F2-4DE3-8813-9B727C945FD0Q34088575-F71F658E-976E-4468-B480-80AA4E145A4FQ34535626-D4619371-8788-4976-A5DB-EB2F9849DA73Q35106099-E7523CE3-A7F6-4B0A-8631-774B65866FEDQ35552815-9B2BE3E9-B1D7-4D0A-8F0A-C54126B92D15Q35649161-EBEC3358-10F5-4998-9E89-7814D31C4625Q35667111-9A8A3F8C-DF17-4F2C-A59B-13FBF9E3C449Q35841791-4A071749-E8FF-4A7D-9B48-92E9E82EEDB7Q35968936-FC459E1E-DF41-41AC-A18F-47285A0AF99CQ35977714-45D8CF72-C42B-46FB-8FBB-E53A1ACAE94AQ36173927-E61063E2-B5A8-4882-AF17-F40F8D10C0F8Q36293841-18B196BC-4B13-42A3-B936-1697D1662844Q36343256-04EFDFE6-EF81-4AA8-9E42-FFD3353A963DQ36787475-B017C376-A697-48D1-B259-75D3966007E4Q37240193-44216E26-A515-4C45-BBB7-21D1A4F02307Q37255859-FFAF4EE4-83ED-47F5-B379-22FE5DD4E67CQ37340255-DF1D1762-002D-4E98-8896-3B853CEA1878Q37340281-55CEB180-60AB-450E-9D89-1BA300D90A46Q37340438-9A7708F7-99E3-4845-A786-9A47B0004F60Q37598581-5267C924-8F32-485A-880F-E363E3090269Q37716310-EC32CCBE-2A52-4596-A97D-DE7B6474BDB5Q38114375-7702CF7F-8CF3-4C7E-B5BC-DC5C7421B681Q38209384-C14C9BCF-E3B7-4353-80FE-520B2D931298Q38262952-DE3E688F-CA31-44A6-8224-7507977F177BQ38418240-EE26A52B-0382-445C-985B-57BB48C966EFQ38419642-D8BF3475-55C9-4A8D-B110-65F92C3320BAQ38760100-3A3092F4-2560-4C0B-9F66-2743668A5E61Q38830153-8D12CCDD-31CF-4696-9F4A-EC5813DD07C5Q38928166-AF5D2CFF-C36F-44E2-847A-FCE6234CBB26Q38954748-32BA9097-680B-4F08-B709-8020F9DFB15D
P2860
Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@ast
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@en
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@nl
type
label
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@ast
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@en
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@nl
prefLabel
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@ast
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@en
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@nl
P2093
P2860
P356
P1433
P1476
Validation of targeted sequenc ...... omosomes 13, 18, 21, X, and Y.
@en
P2093
K H Nicolaides
V Atanasova
P2860
P304
P356
10.1002/PD.4103
P577
2013-04-24T00:00:00Z